669 related articles for article (PubMed ID: 21095521)
1. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
Walsh DS; Portaels F; Meyers WM
Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
[TBL] [Abstract][Full Text] [Related]
2. Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Curr Opin Infect Dis; 2010 Oct; 23(5):445-55. PubMed ID: 20581668
[TBL] [Abstract][Full Text] [Related]
4. [Mycobacterium ulcerans infection].
Dega H; Chosidow O; Barete S; Carbonnelle B; Grosset J; Jarlier V
Ann Med Interne (Paris); 2000 Sep; 151(5):339-44. PubMed ID: 11033467
[TBL] [Abstract][Full Text] [Related]
5. Buruli ulcer.
Einarsdottir T; Huygen K
Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
[TBL] [Abstract][Full Text] [Related]
6. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F
Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445
[TBL] [Abstract][Full Text] [Related]
7. Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection.
Yotsu RR; Nakanaga K; Hoshino Y; Suzuki K; Ishii N
J Dermatol; 2012 Jul; 39(7):587-93. PubMed ID: 22486235
[TBL] [Abstract][Full Text] [Related]
8. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report.
Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F
Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530
[TBL] [Abstract][Full Text] [Related]
9. [Buruli ulcer re-emergent infection].
Adou L
Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):125-33. PubMed ID: 20422927
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form.
Abalos FM; Aguiar J; Guédénon A; Portaels F; Meyers WM
Ann Diagn Pathol; 2000 Dec; 4(6):386-90. PubMed ID: 11149971
[TBL] [Abstract][Full Text] [Related]
12. Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.
Yeboah-Manu D; Peduzzi E; Mensah-Quainoo E; Asante-Poku A; Ofori-Adjei D; Pluschke G; Daubenberger CA
J Leukoc Biol; 2006 Jun; 79(6):1150-6. PubMed ID: 16531561
[TBL] [Abstract][Full Text] [Related]
13. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.
Demangel C; Stinear TP; Cole ST
Nat Rev Microbiol; 2009 Jan; 7(1):50-60. PubMed ID: 19079352
[TBL] [Abstract][Full Text] [Related]
14. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
[TBL] [Abstract][Full Text] [Related]
15. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
Silva MT; Portaels F; Pedrosa J
Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
Hall B; Simmonds R
Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648
[TBL] [Abstract][Full Text] [Related]
17. [Buruli ulcer or Mycobacterium ulcerans infection].
Abgueguen P; Pichard E; Aubry J
Med Mal Infect; 2010 Feb; 40(2):60-9. PubMed ID: 19796893
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis of Mycobacterium ulcerans in the course of rifampicin and streptomycin chemotherapy in Buruli ulcer lesions.
Schütte D; Umboock A; Pluschke G
Br J Dermatol; 2009 Feb; 160(2):273-83. PubMed ID: 19016694
[TBL] [Abstract][Full Text] [Related]
19. Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient.
Toll A; Gallardo F; Ferran M; Gilaberte M; Iglesias M; Gimeno JL; Rondini S; Pujol RM
Clin Exp Dermatol; 2005 Nov; 30(6):649-51. PubMed ID: 16197379
[TBL] [Abstract][Full Text] [Related]
20. The Buruli Ulcer.
Kumar S; Basu S; Bhartiya SK; Shukla VK
Int J Low Extrem Wounds; 2015 Sep; 14(3):217-23. PubMed ID: 26286931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
